Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1576
https://www.valueinhealthjournal.com/article/S1098-3015(13)03481-5/fulltext
Title :
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03481-5&doi=10.1016/j.jval.2013.08.1576
First page :
A578
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1418